Posted on

Second-home visa introduced to foreign investors by immigration, SIER

Surabaya, East Java, Indonesia, Nov 7, 2022 - (ACN Newswire via SEAPRWire.com) - The Directorate General of Immigration and PT Surabaya Industrial Estate Rungkut (SIER) Surabaya, East Java, Indonesia, held a coaching clinic to provide information on second-home visas to foreign investors and consul generals from several countries this week.Consul generals from several countries participated in the "Coaching Clinic on Immigration Services and Second-Home Visa Assistance," which was held in Surabaya on Thursday (November 3, 2022). (ANTARA/HO-PT SIER)The participants of the Coaching Clinic on Immigration Services and Second-Home Visa Assistance, which was held in Surabaya on Thursday (November 3, 2022), included British Prosperity Honorary Consul for Surabaya and East Java Ivy Kamadjaja; Honorary Consul of the Federal Republic of Germany Christopher Tjokrosetio; Honorary Consul of Australia Anthony Clark; and Consul General of Japan in Surabaya Takeyama Kenichi.The coaching clinic aimed to make it easier for foreign businesses to understand the immigration service reform initiated by the Indonesian government, acting director general of immigration at the Ministry of Law and Human Rights, Widodo Ekatjahjana, said in a statement issued on Friday.SIER, which was the first industrial area in Indonesia used by the Directorate General of Immigration as a venue for the coaching clinic, has many tenants and investors from abroad who require easy, fast, and friendly immigration services.So, we met directly with foreign investors in this industrial area of SIER. Through this coaching clinic, we are trying to bring services closer. If there are complaints, we provide immediate solutions," Ekatjahjana informed.He said that he wants the immigration service reform to cover not only administrative matters, but also have an impact on the convenience and ease of investment, which, in the end, could create more jobs.Through the second-home visa policy, which aims to attract investment in the country, foreign investors who put their money and create jobs will be able to stay longer in Indonesia.According to Ekatjahjana, the targets of the second-home visa are certain foreigners or ex-citizens who want to stay and contribute positively to the Indonesian economy.The visa will allow foreigners to stay in the country for five to 10 years and carry out various activities, such as investment and tourism."Submitting an application is very easy through a website-based application visa-online.imigrasi.go.id. There are several document requirements that must be submitted if you want to get this second-home visa," he informed.The documentary requirements include a national passport that is valid for a minimum of 36 months, proof of funds in the form of an account belonging to a foreigner or guarantor with a value of at least Rp2 billion or equivalent, recent color photographs, and a curriculum vitae.The non-tax state revenue rate (PNBP) for second-home visas is Rp3 million, in accordance with the provisions in the Minister of Finance's Regulation No. 2 of 2022.Payments for second-home visas can be made outside the territory of Indonesia through the available PNBP payment portals."This policy will be effective 60 days after the circular letter was issued, namely on October 25, 2022. This immigration policy is one of the non-fiscal incentives that can be a stimulus for certain foreigners to stay and contribute positively to the Indonesian economy in the midst of global economic conditions that are challenging (and) more dynamic," Ekatjahjana said.Meanwhile, the president director of PT SIER, Didik Prasetiyono, said that the Directorate General of Immigration's innovation involving the launch of the second-home visa is a breakthrough that will provide convenience to foreign investors.For this reason, he said he hopes that it will attract more foreign investors to invest in Indonesia, especially in the SIER Surabaya and PIER Pasuruan industrial areas."Next year, we will be overshadowed by a global recession that has the potential to lead to a food, energy, and financial crisis so all countries will need investment. All countries will compete to attract investment. And, it must be remembered: investors' decisions to invest are not only based on economic value, but also factors that support comfort trying, including the matter of immigration services," Prasetiyono highlighted."Of course, this policy will be welcomed by our tenants who come from abroad. SIER currently accommodates more than 200 companies. In SIER, 70 percent of them are tenants from foreign investment. Among them are from Japan, the United States, Australia, China, France, South Korea, Singapore, England, Germany, the Netherlands, and India," he added.Japanese Consul General Kenichi said that he is very happy with the second-home visa policy as many Japanese citizens are keen to live in Indonesia after retirement."This is good news that we have heard. With the second-home visa, Japanese people who have retired can stay longer in Indonesia. So far, many have lived in Bali. But I do not know the exact number. But many want to stay in Indonesia after they retire," he added.Written by: Abdul Hakim, Yashinta Difa, Editor: Rahmad Nasution (c) ANTARA 2022Source article: https://en.antaranews.com/news/258597/second-home-visa-introduced-to-foreign-investors-by-immigration-sier Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

德视佳收购London Vision Clinic Partners Limited 100%已发行股本

HONG KONG, Jan 28, 2022 - (亚太商讯 via SEAPRWire.com) - 领先的全球视力矫正服务提供商─德视佳国际眼科有限公司(「德视佳」或「公司」，连同其附属公司为「集团」，股份代号：1846)欣然宣布，德视佳全资附属公司EuroEyes UK与 London Vision Clinic Partners Limited(「LoVC」)的法定及实益拥有人(「卖方」)订立购股协议，收购LoVC的全部已发行股本。根据购股协议，此次收购的完成现金代价及代价股份合计1,313万英镑；或有代价及盈利支付代价最高1,775万英镑，并可能进行代价调整。最高代价不超过3,087.5万英镑。或有现金代价及盈利支付方面，在第一种盈利目标下，目标公司如能连续四年保持12.5%的利润增长，德视佳将授予价值300万英镑的股份；而在第二种更高速的盈利增长目标下，目标公司如能连续三年实现35%的利润增速，并在第四年实现25%的盈利增速，德视佳将支付975万英镑的现金奖励。于完成后，卖方（或根据购股协议的条款及条件获提名的合伙人）将持有经配发及发行完成代价股份扩大后德视佳已发行股本约1.20%。完成代价股份将按每股完成代价股份8.323港元的发行价发行，发行价较于截至紧接2022年1月20日前交易日止的五个连续交易日于联交所所报的平均收市价每股8.72港元折让约4.6%。该持股将作为股权激励，激励及留存London Vision Clinic的合伙人及核心医生。London Vision Clinic Partners Limited 为视力矫正行业的领先品牌之一，主要提供优质的视力矫正服务，包括PRK、LASIK、SMILE、后房型人工晶体(ICL)植入术以及屈旋光性白内障手术。凭借其细致全面的测试及诊断能力、其在向专家外科医生提供培训及处理复杂病例方面的专业知识，及其享誉全球的声誉，LoVC一直为英国市场的领导者及价格领先者。此外，LoVC是向眼睛老化导致的老花眼患者提供激光视力矫正方案的全球领先者之一，以改善他们的阅读视力。其创办人Dan Zoltan Reinstein教授因在屈光手术领域的发明及重大贡献而在全球享有盛誉，包括发明治疗眼睛老化导致的老花眼患者阅读视力的PRESBYOND®激光融合视觉疗法（PRESBYOND® Laser Blended Vision，已由卡尔蔡司医疗科技商业化），其旨在治疗40岁左右近距离阅读视力下降的老花眼患者。PRESBYOND®提供了一种通过LASIK手术治疗年轻老花眼患者的新方法，无需对眼睛内部进行手术以更换自然晶状体。这与德视佳现有的三焦点人工晶体置换术互为补充，使德视佳在使用现有准分子激光仪器的基础上，拓展40岁左右的老花眼患者群体。此外，London Vision Clinic拥有丰富的人才储备，合并后，德视佳将继续聘用这些业内的资深专家，增强自身的专业实力。其中，Reinstein教授将担任集团国际医疗顾问委员会的医疗总监，使集团能够接触到更多早期可能患有老花眼的患者，为德视佳的专家团队增添巨大价值。Reinstein教授是分层角膜测绘和成像及生物测定领域的生物工程先驱、发明者和开创者。其开发了超高频数字超声扫描技术，发明了Arcscan Insight 100 机器人超声成像以及光学相干层析(OCT)设备，使诊断更为精准，从而提高了激光角膜与ICL植入术的安全性及准确性。其专利生物测定技术的应用为LASIK及SMILE的的临床和科学发展做出了重大贡献。此外，LoVC全资附属公司London Vision Clinic Training将展开收购后业务，主要从事提供屈光手术相关的在线及线下培训。Reinstein教授将为London Vision Clinic Training的主讲人和培训师之一。此外，在目标公司财务状况方面，London Vision Clinic Partners Limited展现出较强的增长潜力，由2020年全年息税前利润9万4千英镑大幅增至2021年的219万英镑，这一增长主要是由于目标公司于2021年初开始，在经营方式及运营管理方面做出了积极优化及改进。德视佳的创始人，董事长兼首席执行官约根森博士表示：「集团一直积极扩大现有的欧洲版图， 收购LoVC绝对符合我们的增长战略。我们相信是次收购有助集团迅速进军伦敦高端市场，并提供屈光及老花眼手术，从而产生协同效应，支持集团的长期增长，以及巩固市场领先地位。随着LoVC 及其 PRESBYOND®激光融合视觉疗法并入德视佳，集团能够接触更多早期可能患有老花眼的患者。在完全LoVC 收购后，我们计划于未来一至两年于伦敦开设一家新诊所，以进一步扩大我们的服务网络，为更多患者提供优质的眼科护理服务。」关于德视佳国际眼科有限公司德视佳成立于1993年，是视力矫正行业的领先品牌之一，该产品结合了德国眼科学的卓越经验和超过25年的经验以及个性化的客户服务。德视佳是为数不多，具有广泛地理覆盖范围的眼科诊所之一，业务遍及德国、丹麦和中国。该集团的视力矫正服务包括：(i)屈光激光手术(包括ReLEx Smile和Femto LASIK)；(ii)晶体植入手术(ICL)；(iii)晶体置换手术(包括单焦点和三焦点晶体置换手术)和(iv)其他(包括PRK / LASEK和ICRS植入术)。此新闻稿由博达浩华国际财经传讯公司代表德视佳国际眼科有限公司发布。如有垂询，请联络：博达浩华国际财经传讯公司电邮：euroeyes.hk@pordahavas.com Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

Read More
Posted on

EuroEyes Acquires 100% Issued Shares in London Vision Clinic Partners Limited

HONG KONG, Jan 28, 2022 - (ACN Newswire via SEAPRWire.com) - EuroEyes International Eye Clinic Limited ("EuroEyes" or the "Company", together with its subsidiaries, the "Group", stock code: 1846), a leading global vision correction service provider, is pleased to announce that EuroEyes UK, a wholly-owned subsidiary of the Company, has entered into a Share Purchase Agreement ("Share Purchase Agreement") to acquire the entire issued shares in London Vision Clinic Partners Limited ("LoVC") with the legal and beneficial owners of LoVC ("Sellers").According to the share purchase agreement, the total cash consideration and consideration shares for the acquisition shall be GBP13,130,000; the maximum amount of earn out payment shall be GBP17,745,000, and subject to the Consideration Adjustment. The maximum consideration for the Acquisition shall be GBP 30,875,000. In terms of earn out payment, under the first profit target, if the Seller maintains an EBIT growth of 12.5% for four consecutive years, EuroEyes shall procure the allotment and issue to the Seller such number of shares having an aggregate value of up to GBP3,120,000; Under the second profit target, if the Seller achieves an EBIT growth rate of 35% for three consecutive years, and 25% in the fourth year, Euroeyes shall pay GBP 9,750,000 to the Seller.Upon Completion, the Seller (or the Partners as nominated in accordance with the terms and conditions of the Share Purchase Agreement) will hold approximately 1.20% of the issued share capital of EuroEyes as enlarged by the allotment and issue of the Completion Consideration Shares. The Completion Consideration Shares will be issued at the issue price of HK$8.323 per Completion Consideration Share which represents a discount of approximately 6.9% to the average closing price of HK$8.94 per Share as quoted on the Stock Exchange on the five consecutive trading days ended on the trading day immediately preceding 20 January 2022. The shareholding will serve as an share incentive to motivate and retain London Vision Clinic's partners and key surgeons. London Vision Clinic Partners Limited is one of the leading brands in the vision correction industry and principally engaged in the provision of premium vision correction services, including PRK, LASIK, SMILE, phakic lens (ICL) surgery and refractive cataract surgery. It has been the market segment and price leader in the UK with its capabilities in conducting detailed and comprehensive testing and diagnosis and has a world reputation for expertise in providing training to specialist surgeons and managing complicated cases.Moreover, LoVC is a world leader in offering laser vision correction option for reading vision in ageing eyes (presbyopia). Its founder, Professor Dan Zoltan Reinstein, has garnered worldwide reputation for his inventions and major contributions to the refractive surgery field, including the invention of the PRESBYOND Laser Blended Vision treatment as commercialised by Carl Zeiss Meditec for presbyopia which is designed to treat patients from the age of 40 years old, who have developed presbyopia (decreased ability to read up close). PRESBYOND provides an additional method of treating younger patients with presbyopia by a LASIK procedure, which avoids the need to perform surgery inside the eye to replace the natural lens. Presbonyd will a perfect addition to EuroEyes' trifocal lens exchange surgery, which enables EuroEyes to treat a larger group of presbyopia patients over 40 years old without buying new equitments.In addition, London Vision Clinic has a talent pool of high-quality surgeons and doctors. Upon completion of the Acquisition, EuroEyes will continue to hire the expert group to further strengthen its medical expertise. What's more, Professor Reinstein will serve as a medical director of the international medical advisory board of the Group, which will add tremendous value to EuroEye's expert team. Professor Reinstein is also a bioengineering pioneer, inventor and developer in the field of layered corneal mapping and imaging and biometry. He had pioneered corneal imaging and biometry with very high-frequency digital ultrasound scanning, invented the Arcscan Insight 100 robotic scanner as well as optical coherence tomography (OCT) devices, enabling superior diagnostic capabilities to improve the safety and accuracy of both laser corneal and ICL surgery. Application of his patented biometric technologies has resulted in major contributions to the clinical and scientific development of both LASIK and SMILE.Moreover, London Vision Clinic Training, a wholly-owned subsidiary of LoVC, will start business afer acquisition, and will be principally engaged in the provision of online and offline training relating to refractive surgery. Professor Reinstein will be one of the key speakers and trainers at London Vision Clinic Training.In addition, in terms of the financial position of the target company, London Vision Clinic Partners Limited has shown strong growth potential, with a substantial increase in EBIT from GBP 94,000 in 2020 to GBP 2.19 million in 2021. This growth is mainly due to the proactive optimizations and improvements in its business model and operation management made by LoVC started in early 2021.Dr. Jorn Slot Jorgensen, Founder, Chairman and CEO of EuroEyes said, "The Group has been actively expanding its current footprint in Europe and the acquisition of LoVC is definitely in line with our growth strategy. We believe that the acquisition will enable the Group to quickly tap into the high-end London market for refractive and presbyopic surgeries, create synergy and support the long-term growth of the Group, thereby enhancing its market leader status. With the additions of LoVC and its PRESBYOND Laser Blended Vision treatment, the Group will be able to reach out to more potential patients who are suffering from presbyopia at an early stage. Following the acquisition of LoVC, we plan to open a new clinic in London within 1-2 year, to further expand our service network and provide more patients with high-quality eye care services."About EuroEyes International Eye Clinic LimitedEuroEyes was established in 1993 and is one of the leading brands in the vision correction industry that combines German ophthalmology excellence and over 25 years of experience with individualised customer care. EuroEyes is one of the few eye clinic groups with a far-reaching geographical coverage, with operations in Germany, Denmark and the PRC. The Group's vision correction services include (i) refractive laser surgery (which includes ReLEx smile and Femto LASIK); (ii) phakic lens (ICL) surgery; (iii) lens exchange surgery (which includes the monofocal and trifocal lens exchange surgery) and (iv) others (which include PRK/LASEK and ICRS implantation). Issued by Porda Havas International Finance Communications Group for and on behalf of EuroEyes International Eye Clinic Limited. For further information, please contact: Porda Havas International Finance Communications Group Email: euroeyes.hk@pordahavas.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

70-year-old doctor charged with molesting female patient in Yishun clinic

SINGAPORE - An elderly doctor appeared in a district court on Thursday (Aug 26) after he allegedly molested a female patient at a clinic where he worked. Chua Kee Loi, 70, is accused of committing the offence on Aug 5 last year. He faces one charge of molestation. He was at the Chua Clinic and Surgery in Yishun Avenue 3 around 7.30pm that day when he allegedly touched the woman's right cheek and breast over her clothing with his left hand. She cannot be named, because of a gag order. The Singaporean doctor's bail was set at $10,000 on Thursday and his case has been adjourned to Sept 23. Anyone convicted of molestation can be jailed for up to two years and fined or caned. Chua cannot be caned as he is over 50 years old. More on this topic   Related Story Charges withdrawn for S'pore doctor accused of molestation after 'victim' admitted to lying   Related Story Courts & Crime: Read more stories

Read More
Posted on

Rimba Raya Floating Clinic Supplying Health Care to the Community along the Seruyan River

JAKARTA, May 3, 2021 - (ACN Newswire via SEAPRWire.com) - The Rimba Raya Floating Clinic was introduced into the project area as a means to improve community access to health services in and around the Rimba Raya working area which is located along the Seruyan River. In cooperation with the Seruyan District Health Office, the Rimba Raya Floating Clinic has delivered health services three times in 2020 (Jan, Aug, Nov) and once already in 2021 (March).Medical check-up by Medical personnel in Belanti Village(L) & Medical personnel with Rimba Raya Staff(R).Dr Ristya Aulia of the Floating Clinic medical team.Medical examination by Medical personnel in Tampudau Village(L) & Cempaka Baru Village(R), Miss Irus is checked by the nurse.During these trips, several healthcare services are provided including general medical check-ups which help determine the health of local people by recording their weight, height, blood pressure and temperature. A general wellness check is also done. Additionally, pregnant women are examined to ensure that the pregnancy is advancing normally and that the mother to be is in good health. Children are also examined to monitor their growth and physical development. Other community members are examined for health problems such as myalgia, hypertension, cholesterol, URTI (upper respiratory tract infection), gastritis, eating disorders, skin infections and allergies. Medical personnel who provide these services on each floating clinic trip include a doctor, midwives and nurses who are normally based in Puskesmas Kuala Pembuang 1 and Kuala Pembuang 2.Dr. Ristya Aulia, a member of the Floating Clinic medical team said; "Thank you Rimba Raya for introducing this initiative that provides much needed additional health services to the villages along the Seruyan river. It is my hope that the facilities and infrastructure will improve over time and that the floating clinic will continue to provide this service and that trips into the project area will happen more frequently."An elderly woman, Mrs. Irus from Cempaka Baru Village said, "I am very happy with the services provided by the Rimba Raya Floating Clinic, especially because the doctor was able to visit me at my house. I live in a remote village it makes me feel better to know that I can receive treatment in my own home. I live alone and I can't afford to pay for health care if I have to go outside the village."The last two trips conducted by the floating clinic took place from 10-12 November 2020 and 22-24 March 2020. There were 10 locations targeted which included 8 villages and 2 hamlets, namely; Pematang Limau, Tanjung Rangas, Muara Dua (Tampudau and Belanti Hamlet), Jahitan, Baung (west and east), Cempaka Baru, Palingkau and Ulak Batu. A total of 706 patients received health care where 60.91% (or 430 patients) were female.The Rimba Raya Biodiversity Reserve Floating Clinic is equipped to supply 86 types of medicines. Vitamins are also supplied, particularly to children, pregnant women and the elderly. Reportedly, during these health outreach trips, 12 common health problems were diagnosed with the top three being hypertension (24.08%), myalgia (a chronic muscle disorder) - 21.67%, and URTI (Upper Respiratory Tract Infection) - 17%. Based on the data collected during these trips, it is also known that older people are the most susceptible to various illnesses and therefore, in this region, people aged 50 and older are the most vulnerable. 42.78% or 302 patients who received treatment, fell into this category. "Rimba Raya Floating Clinic is vital to villagers who require health services, particularly because some areas in the Seruyan are difficult to reach and as a result, there is a severe lack of regular health care. I would like to see an increase in the frequency of these health service trips," said Anggi Mulyawan, Staff of TNTP SPTN II Kuala Pembuang. Head of Seruyan District Health Office, Mahdiniansyah added, "Because there has been limited availability of regional government funding, the field health program introduced by Rimba Raya has been very well received by all community members. A good example of how Rimba Raya has positively impacted this area is when they helped supply medicines to people who were victims of the major flooding that occurred in the Seruyan District in 2020. Additionally, waterborne diseases have been reduced after Rimba Raya introduced initiatives that supply clean drinking water to villagers through the provision of individual water filters and newly constructed water purifying systems. The Head of Seruyan District expressed his gratitude for the assistance of PT. Rimba Raya Conservation in providing free health services to 10 villages and hamlets in the Seruyan District.""Rimba Raya hopes to have better cooperation and support from all parties involved in this effort to improve health services in the region. Access to basic health care services is as a fundamental human right and the needs of all community members should be adequately met," said Sylviana Andhella, Executive Director of Rimba Raya Conservation. Rimba Raya Duty"By protecting forests, we protect all the life in them and contribute to balancing the global climate. We empower communities to be involved in protecting peat swamp forests. Together we love the earth so that its sustainability is maintained." - Djonni Andhella, President Director of Rimba Raya Conservation.Abou Rimba RayaThe Rimba Raya Biodiversity Reserve, an InfiniteEARTH Project, is one of the largest REDD+ projects in the world, protecting nearly 65,000 hectares of peat swamp forest in Central Kalimantan, the world's first REDD+ project verified under the Verra Sustainable Development Verified Impact Standard (SDVista) and achieved the highest rating possible, contributing to all 17 United Nations' Sustainable Development Goals (SDGs) while retaining the coveted Triple Gold status under the global Climate, Community and Biodiversity (CCB) standard in the voluntary carbon market. It is a living example of an economically viable alternative to deforestation. Visit https://infinite-earth.com.The project has reduced Indonesia's emissions by preserving tropical peat swamp forest, avoiding large-scale deforestation, drainage and conversion to palm oil plantations. Bordering the eastern boundary of the Tanjung Puting National Park in the Seruyan River watershed, the Rimba Raya project is rich in biodiversity with over 100 threatened and endangered species, including the endangered Bornean orangutan. Visit https://rimba-raya.com.Rimba Raya Conservation as the field implementer, empowers the community to be involved in maintaining and preserving peat swamp forest ecosystems with the following approach: Empowered Communities, Healthy Forests, Maintained Climate, and supporting the achievement of the SDG targets in the assisted villages of the Rimba Raya Biodiversity Reserve.Health ProtocolThis activity was carried out with reference to the WHOs COVID-19 Health Protocols. Contacts:Frita JunitaCommunication Officer - Rimba Raya ConservationE: rimbarayajakarta@gmail.comH: +62 857-1743-7001U: www.rimba-raya.comRimba Raya MedSos:Instagram: http://instagram.com/rimbarayaproject/Facebook: https://www.facebook.com/RimbaRayaForestTwitter: https://twitter.com/rimba_raya_ Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Japanese Red Cross Kumamoto Hospital and Toyota to Begin Utilization Demonstration of the World’s First Fuel Cell Electric Vehicle Mobile Clinic

Toyota City, Japan, Mar 31, 2021 - (JCN Newswire via SEAPRWire.com) - Japanese Red Cross Kumamoto Hospital and Toyota Motor Corporation (Toyota) have agreed to begin demonstration testing of the world's first(1) fuel cell electric vehicle mobile clinic (FCEV mobile clinic) that uses hydrogen to generate electricity, by the summer of 2021. The organizations aim to use this demonstration testing to confirm the effectiveness of a commercial fuel cell electric vehicle (FCEV) in areas of medicine and disaster countermeasures, and to achieve carbon neutrality. By building an operational model of an FCEV mobile clinic for utilization during normal times and times of disaster, they will also contribute to the reduction of CO2 emissions to help prevent global warming.Typhoons, heavy rains and other natural disasters have increased in frequency over recent years, causing not only power outages for homes and evacuation centers, but also increasing the need for medical services in disaster-affected areas. In light of this, Toyota has been working with Japanese Red Cross Kumamoto Hospital since around the summer of 2020 to look into how these issues could be addressed. As a result, the two organizations have agreed to contribute to solving issues associated with natural disasters. This would be achieved with an FCEV mobile clinic that could be used to deliver medical services during normal times, and could also be used to support disaster relief efforts during times of disaster, while supplying electricity in disaster-affected areas as part of a disaster response.Toyota has developed the FCEV mobile clinic based on its Coaster minibus, with the power source using the Toyota fuel cell system(2) employed by the "Mirai" FCEV. On the road, it exhibits a superior environmental performance with no CO2 emissions or substances of concern (SoC), while offering a low-noise, low-vibration driving experience.With multiple 100 VAC accessory power outlets supplied not only inside the vehicle but also outside the cabin, the vehicle is able to supply electricity to a variety of electrical products. It is also equipped with an external DC electric power supply system that delivers a high-output, large-capacity supply of power(3) (9 kW max output, approx. 90 kWh supply capacity). Inside, the vehicle combines air conditioning with an exhaust system and HEPA filter(4) to improve infection control for occupants when working.Japanese Red Cross Kumamoto Hospital and Toyota believe the FCEV mobile clinic has the ability to create new value not found in conventional mobile clinics. Bringing their respective knowledge and technologies to the development. and utilizing the exceptional environmental performance that is unique to FCEVs, they aim to explore expanded applications for a mobile clinic that can reduce stress levels for both medical staff and patients. Demonstration testing seeks to achieve a reassuring power supply during times of disaster with a view to effective utilization of the vehicle's power supply capabilities in medical settings and disaster-affected areas. In addition to emergency transportation of patients, they believe the FCEV mobile clinic has the potential for a wide range of applications and developments in the healthcare field, including supplying electricity to blood donation buses and medical examination vehicles, traveling to less-populated areas as a mobile clinic, and a mobile PCR testing vehicle.(1) As of March 2021, according to Toyota Motor Corporation.(2) Fuel cell system installed in the first-generation Mirai.(3) The power that can be supplied and the power amount may differ, depending on the performance of the power supply unit, amount of hydrogen remaining, and power consumption. External power feeding devices are sold separately.(4) HEPA stands for high-efficiency particulate air (filter). According to JIS standards, HEPA filters are defined as having a particle capture rate of at least 99.97% of particles measuring 0.3 μm in diameter at a rated air flow, and an initial pressure loss of 245 Pa or less. Copyright 2021 JCN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

The third TDMall in the world opened in Sydney, Australia

HONG KONG, Mar 16, 2021 - (ACN Newswire via SEAPRWire.com) - TDMall (Group) Limited, a subsidiary of Tianda Pharmaceuticals Limited (listed on the main board of the Hong Kong Stock Exchange: 00455) has invested in the establishment of modern-style Chinese medicine clinic - TDMall, and grandly opened its third TDMall in the world, TDMall (Sydney), on 14 March in Macquarie Park, Sydney, Australia. TDMall is committed to bringing the unique benefits Chinese medicine to the people in Sydney's communities, in New South Wales and all over Australia by providing premium, accessible and comprehensive Chinese medicine health services, in order to fulfill its mission of helping people in different parts of the world with Chinese medicine! Officiating guests at the ribbon-cutting ceremony, including Mr. John Alexander OAM, MP, Member for Bennelong, New South Wales(first left), Mr. Zhou Guangming, the Australian Chinese community celebrity (second left), Mr. Simon Zhou, City of Ryde Councilor (third left).TDMall (Sydney)'s registered Chinese medicine practitioners give diagnosis to every individual in the free consultation activity to last until end of April.A number of distinguished guests attended the opening ceremony of TDMall (Sydney), including Mr. John Alexander OAM, MP, Member for Bennelong, New South Wales, Mr. Simon Zhou, City of Ryde Councilor, and Australian Chinese community celebrities including Mr. Zhou Guangming. TDMall (Sydney) is TDMall (Group)'s third Chinese medicine clinic in the world after its first clinic TDMall (Zhuhai) grandly opened on 2 May 2019 and second clinic TDMall (Hong Kong) opened in a gong-striking ceremony on 24 February 2020. TDMall (Sydney) focuses on Chinese internal medicine, Chinese medicine gynecology, Chinese medicine orthopedics & pain management, Chinese medicine cosmetology, Chinese medicine acupuncture, weight management, and cancer prevention & rehabilitation. As a proactive "giving back to the community" initiative, TDMall (Sydney) will conduct a free Chinese medicine consultation activity until the end of April to provide free consultation to 10 patients every week on their first visit to the clinic. Please make appointments by phone as the service is available on a first come, first served basis.Mr. John Alexander OAM, MP, Member for Bennelong, New South Wales gave a speech behalf of the guests, saying he welcomed TDMall to Macquarie Park, Australia's premier innovation hub to offer Chinese medicine consultation and treatment services. He added that TDMall (Group)'s decision to choose Sydney for its third TDMall reflects the close bilateral relationship between Australia and Asia.Mr. Fang Wenquan, Chairman of Tianda Pharmaceutical and Founder of TDMall, said that TDMall has achieved a domestic and foreign business layout following the opening of TDMall (Sydney). TDMall (Group) has taken 3 years opening one TDMall every year steadily and prudently to accomplish Step 1 of its "three-step" development plan. TDMall is ready to take Step 2, which includes the further expansion in the Greater Bay Area targeting Shenzhen, Guangzhou and other prefecture-level or county-level cities with the aim of opening more than 100 TDMall clinics in Guangdong province while exploring opportunities to expand to other domestic and foreign markets at the right time, as well as the construction of a Cloud technology-based Chinese medicine platform "TDMall on Cloud" to provide online AI-assisted remote diagnosis as an attempt to facilitate Chinese medicine services across country borders. TDMall will take Step 3 upon achieving Step 2, expanding the business across China and worldwide with the aim of opening more than 10,000 TDMall clinics. By integrating modern medical science with other innovative technologies, TDMall strives to become the leading Chinese medicine clinic brand, while continuing to promote the inheritance, innovation and development of Chinese medicine, as well as the use of Chinese medicine in managing people's health worldwide. EnquiryTianda Pharmaceuticals LimitedInvestor Relations DepartmentT: + 852 2545 3313E: ir@tianda.com Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Orchard dental clinic to be taken off Chas

A dental clinic in the Orchard area will be removed from the Community Health Assist Scheme (Chas) after it was found to have made numerous improper claims for government subsidies. These claims made by Jesselton Dental Centre at Pacific Plaza exceeded the allowed limit for Chas subsidies and were not accompanied by proper supporting documentation, the Ministry of Health (MOH) said yesterday. "Audits on Jesselton Dental Centre conducted in late 2018 to 2019 revealed severe non-compliance," it said. Of the over 200 claims for Chas subsidies from the clinic that were audited, about 96 per cent were found to be non-compliant, said the ministry. The termination was issued on Dec 10 and will take effect from Saturday. MOH advised affected patients to visit other nearby Chas-accredited dental clinics instead. In response to queries from The Straits Times, a Jesselton Dental Centre spokesman said yesterday that the claims were made by an administrative staff and a member of the clinic's management team between 2017 and 2018. Both of them were let go immediately after they were found to have made the claims. "We are working alongside the authorities to remedy the situation. Our patients always come first," the spokesman said. MOH said it was informed in April by the clinic in Scotts Road that its ownership and licensee had changed hands from Resilient Healthcare Group to Alliance Management Group. "This cessation of Resilient Healthcare Group as the licensee, coupled with the extent of Jesselton Dental Centre's non-compliance, made the termination of the clinic from Chas necessary," it said. "MOH will continue to investigate the clinic even with the change in ownership." The clinic can still treat patients, provided its dentists hold valid registration and practising certificates from the Singapore Dental Council, but the treatment it provides will not be covered by Chas subsidies. "MOH encourages patients to actively engage their doctors and dentists if they have any queries on their bills," said the ministry. "We also remind healthcare professionals to uphold a high standard of professionalism and adhere to their ethical code and ethical guidelines." In October 2019, two dentists from Phoenix Dental Surgery clinic became the first to be charged with cheating through Chas. Teo Eu Gene pleaded guilty to 25 counts of cheating by submitting false Chas claims for dental procedures and was sentenced to 46 weeks' jail. His former colleague, Andy Joshua Warren, faced similar charges. To check Chas claims made on their behalf, Chas, Pioneer Generation and Merdeka Generation card holders can log in to the "My Chas" module on the Chas website, or call the Chas hotline on 1800-275-2427. They can also contact MOH, if they come across any suspicious or unusual claims, by calling the ministry on 1800-225-4122 or by e-mailing MOH_QSM@moh.gov.sg

Read More